BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Yunu Extends Free Cancer Center Use of Platform for All Children’s Oncology Group Clinical Trials

  September 12, 2024

   · 

  3 min read
• Press Releases

  Health Canada Approves KEYTRUDA® as monotherapy for the treatment of adult and pediatric patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumours that have progressed following prior treatment and who have no satisfactory alternative treatment options

  September 12, 2024

   · 

  6 min read
• Press Releases

  CareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial Officer

  September 12, 2024

   · 

  4 min read
• Press Releases

  GT Medical Technologies, Inc. Secures $35 Million Venture Loan Facility from Horizon Technology Finance

  September 12, 2024

   · 

  4 min read
• Press Releases

  Novotech Wins Prestigious Brandon Hall Gold Award for CRA Monitoring Simulation Program under the category of Best Competencies and Skill Development

  September 12, 2024

   · 

  3 min read
• Press Releases

  Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

  September 12, 2024

   · 

  8 min read
• Press Releases

  REVEAL GENOMICS® Unveils TNBCDX®: the First Genomic Test Designed for Early-stage Triple-Negative Breast Cancer

  September 12, 2024

   · 

  4 min read
• Press Releases

  Marinus Pharmaceuticals Announces Agenda and Speakers for Investor & Analyst Day on September 20, 2024

  September 12, 2024

   · 

  5 min read
• Press Releases

  EMD Serono Unveils New MAVENCLAD® Four-Year Data Highlighting Benefits of Early Treatment and Sustained Efficacy Across Multiple Measures of Disease Activity

  September 12, 2024

   · 

  13 min read
• Press Releases

  Agendia’s FLEX Study Reaches Enrollment of Over 17,000 Early-Stage Breast Cancer Patients Across Diverse Population

  September 12, 2024

   · 

  5 min read